Centre for Contact Lens Research Archives

CLU Issue 31: Overnight Lens Wear and Orthokeratology

Wednesday, April 27 2016 | 00 h 00 min | Vision Science

Issue 31 of the Centre for Contact Lens Research’s Contact Lens Update explores extended wear of contact lenses, including the fields of myopia...

CLU Issue 28 Spotlights Bacteria-Fighting Technology

Wednesday, November 4 2015 | 00 h 00 min | News, Vision Science

Issue 28 of Contact Lens Update, published by the Centre for Contact Lens Research (CCLR), University of Waterloo, features a “chemical nose” for...

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

Visioneering Technologies, Inc, producer of the NaturalVue® Multifocal 1 Day Contact Lenses (NVMF), continued its release of the 1-year prospective data of its ongoing multi-center, randomized, double-masked, controlled trial (RCT) at the Association for Research in Vision and Ophthalmology (ARVO).

Learn More

Voila Optik March-April 2024 GIGI STUDIOS Hilary

New Gradient and Lighter Acetate

GIGI STUDIOS presents HILARY (6889/0), a design crafted from high-quality Italian acetate.

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

In time for Vision Health Month this May, the Canadian Ophthalmological Society (COS) has released a new survey to assess Canadians’ awareness, understanding, and concerns around eye and vision health.

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

Marcolin and K-Way®, French brand born in 1965 – currently owned by Turin-based group BasicNet – and known worldwide for its revolutionary rain jackets, announce they have signed an exclusive licensing agreement.

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

Company Highlights Scientific Program Slated for Annual Meeting in Seattle

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

Learn More

New Gradient and Lighter Acetate

GIGI STUDIOS presents HILARY (6889/0), a design crafted from high-quality Italian acetate.

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

Company Highlights Scientific Program Slated for Annual Meeting in Seattle

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

Learn More

New Gradient and Lighter Acetate

GIGI STUDIOS presents HILARY (6889/0), a design crafted from high-quality Italian acetate.

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

Company Highlights Scientific Program Slated for Annual Meeting in Seattle

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

Learn More

New Gradient and Lighter Acetate

GIGI STUDIOS presents HILARY (6889/0), a design crafted from high-quality Italian acetate.

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

Company Highlights Scientific Program Slated for Annual Meeting in Seattle

Tag: Centre for Contact Lens Research

CLU Issue 31: Overnight Lens Wear and Orthokeratology

CLU Issue 28 Spotlights Bacteria-Fighting Technology

Featured Posts

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

New Gradient and Lighter Acetate

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

New Gradient and Lighter Acetate

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

New Gradient and Lighter Acetate

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort

New Data from VTI’s PROTECT Clinical Trial for Myopia Progression Control Presented at ARVO

New Gradient and Lighter Acetate

Eye Health Survey Uncovers Canadians’ Concerns About Recent Symptoms Affecting Their Eyes & Vision

Marcolin: Exclusive Licensing Agreement Signed with K-WAY®

ARVO 2024: Studies Reinforce Confidence in CooperVision Myopia Management Interventions & Explore Contact Lens Comfort